Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes

56Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Astaxanthin is a red carotenoid pigment which exerts multiple biological activities. However, little is known about the effects of astaxanthin on matrix metalloproteinases (MMPs) in OA. The present study investigated the effects of astaxanthin on MMPs in human chondrocytes. Human chondrocytes were pretreated with astaxanthin at 1, 10 or 50 μM, then, cells were stimulated with IL-1β (10 ng/ml) for 24 h. MMP-1, MMP-3 and MMP-13 were observed. We found that astaxanthin reduced the expression of MMP-1, MMP-3 and MMP-13 as well as the phosphorylation of two mitogen-activated protein kinases (MAPK) (p38 and ERK1/2) in IL-1β-stimulated chondrocytes. Astaxanthin also blocked the IκB-α degradation. These results suggest that astaxanthin may be beneficial in the treatment of OA. © 2014 Elsevier B.V.

Cite

CITATION STYLE

APA

Chen, W. P., Xiong, Y., Shi, Y. X., Hu, P. F., Bao, J. P., & Wu, L. D. (2014). Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes. International Immunopharmacology, 19(1), 174–177. https://doi.org/10.1016/j.intimp.2013.12.007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free